lamivudine has been researched along with Erythrophagocytic Lymphohistiocytosis, Familial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Amoudi, S; Al-Mashhadani, S; Aleem, A; Siddiqui, N | 1 |
1 other study(ies) available for lamivudine and Erythrophagocytic Lymphohistiocytosis, Familial
| Article | Year |
|---|---|
Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide.
Topics: Etoposide; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Remission Induction | 2005 |